標(biāo)題: Titlebook: Recent Advances and Future Directions in Bone Marrow Transplantation; Proceedings of a Sym Siegmund J. Baum,George W. Santos (Professor of [打印本頁] 作者: children 時(shí)間: 2025-3-21 18:52
書目名稱Recent Advances and Future Directions in Bone Marrow Transplantation影響因子(影響力)
書目名稱Recent Advances and Future Directions in Bone Marrow Transplantation影響因子(影響力)學(xué)科排名
書目名稱Recent Advances and Future Directions in Bone Marrow Transplantation網(wǎng)絡(luò)公開度
書目名稱Recent Advances and Future Directions in Bone Marrow Transplantation網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Recent Advances and Future Directions in Bone Marrow Transplantation被引頻次
書目名稱Recent Advances and Future Directions in Bone Marrow Transplantation被引頻次學(xué)科排名
書目名稱Recent Advances and Future Directions in Bone Marrow Transplantation年度引用
書目名稱Recent Advances and Future Directions in Bone Marrow Transplantation年度引用學(xué)科排名
書目名稱Recent Advances and Future Directions in Bone Marrow Transplantation讀者反饋
書目名稱Recent Advances and Future Directions in Bone Marrow Transplantation讀者反饋學(xué)科排名
作者: 使?jié)M足 時(shí)間: 2025-3-21 20:55
https://doi.org/10.1007/978-1-4612-3762-4anemia; bone marrow; lymphocytes; lymphoma; transplantation作者: COW 時(shí)間: 2025-3-22 03:02 作者: Radiation 時(shí)間: 2025-3-22 05:11 作者: Fulsome 時(shí)間: 2025-3-22 10:35 作者: commensurate 時(shí)間: 2025-3-22 13:03 作者: 猛然一拉 時(shí)間: 2025-3-22 17:10
Allogeneic and Autologous Marrow Transplants in Acute Nonlymphoblastic Leukemia (ANLL) (1–4). Problems with marrow transplantation such as leukemia relapse, graft-versus-host disease (GVHD) and viral infections have been identified and solutions to these problems are being actively pursued in many centers around the world.作者: 無法取消 時(shí)間: 2025-3-22 21:25
Allogeneic Bone Marrow Transplantation for Leukemia—Japanese Experience in 1980 after the formation of the Japan BMT study group of 31 hospitals supported by a grant from the Ministry of Health and Welfare of Japan. This paper reports the data obtained from the registry of the Japanese study group. Member hospitals are listed in Table 1.作者: GIBE 時(shí)間: 2025-3-23 05:15 作者: Asparagus 時(shí)間: 2025-3-23 08:23 作者: photophobia 時(shí)間: 2025-3-23 10:15
Autologous Marrow Transplantation for Hodgkin’s and Non-Hodgkin’s Lymphoma: Preliminary Results UsinCurrent combination chemotherapy regimens can produce durable remission in many patients with Hodgkin’s disease (1) and certain intermediate- and high-grade non-Hodgkin’s lymphomas (2). However, patients who do not achieve durable remission after these therapies usually respond poorly to salvage chemotherapies (3,4).作者: emission 時(shí)間: 2025-3-23 14:25
James P. OKunewick,Deborah L. Kociban,Mary J. Buffo,Christine K. Young作者: 惰性女人 時(shí)間: 2025-3-23 21:20 作者: 具體 時(shí)間: 2025-3-24 00:21
Y. Kodera,Y. Morishima,Y. Moriyama,T. Mori,A. Kanamaru,K. Shinohara,T. Ito,H. Mugishima,T. Masaoka作者: Paraplegia 時(shí)間: 2025-3-24 02:43 作者: 農(nóng)學(xué) 時(shí)間: 2025-3-24 09:57 作者: Gudgeon 時(shí)間: 2025-3-24 11:55 作者: Daily-Value 時(shí)間: 2025-3-24 15:46 作者: Relinquish 時(shí)間: 2025-3-24 19:42
Leonard J. Horwitz,Karel A. Dicke,Sundar Jagannath,Gary Spitzer作者: 襲擊 時(shí)間: 2025-3-24 23:23
G. W. Santos,A. M. Yeager,R. Saral,W. H. Burns,J. R. Wingard,R. Jones,R. F. Ambinder,S. D. Rowley,W.作者: AND 時(shí)間: 2025-3-25 05:17
V. Rizzoli,L. Mangoni,A. M. Carella,G. Torlontano,M. Aglietta,L. Resegotti,E. Madon,R. Mozzana,A. Po作者: 高度 時(shí)間: 2025-3-25 07:44 作者: oxidize 時(shí)間: 2025-3-25 15:02
L. H. Coutinho,A. Will,J. Chang,N. G. Testa,T. M. Dexter作者: 拱墻 時(shí)間: 2025-3-25 19:26 作者: 乳白光 時(shí)間: 2025-3-25 23:04
Recent Advances and Future Directions in Bone Marrow TransplantationProceedings of a Sym作者: 獨(dú)特性 時(shí)間: 2025-3-26 01:56 作者: 傲慢物 時(shí)間: 2025-3-26 07:21 作者: 折磨 時(shí)間: 2025-3-26 11:08
0172-6803 the Uphoff and Congdon was involved in the first hypothesis of Gengozian and Makinodum (5) that successful transplantation of syngeneic and increasing the radiation dose will increase allogeneic bone marrow into irradiated immunologic tolerance for allogeneic implants.978-1-4612-8339-3978-1-4612-3762-4Series ISSN 0172-6803 作者: infantile 時(shí)間: 2025-3-26 16:35
Utilization of Monoclonal Antibodies for Autologous Bone Marrow Transplantationion and 2 Burkitt’s lymphoma patients continued in remission for more than 5–31 months after the BMT, suggesting autologous BMT with these monoclonal antibodies may be an effective mode of therapy for Null-ALL and Burkitt’s lymphoma especially when applied at an early stage of the disease.作者: grotto 時(shí)間: 2025-3-26 19:23
Introductiontion of syngeneic and allogeneic bone marrow into irradiated mice (1). Subsequently, these investigators theorized that a humoral factor probably was responsible for the radiation protection, as documented by the injection of rat bone marrow into irradiated mice (2).作者: 原告 時(shí)間: 2025-3-26 23:32 作者: 樸素 時(shí)間: 2025-3-27 01:29 作者: Harness 時(shí)間: 2025-3-27 06:27
Oncogenes in Acute Myelogenous Leukemia alterations of oncogene expression can result in neoplastic transformation in experimental models, expression of cellular oncogenes in human leukemias is the subject of intense investigation. Recently we reviewed the role of oncogenes in human leukemias (4). In this review we focus on oncogene abnormalities in acute myeloid leukemia (AML).作者: 最低點(diǎn) 時(shí)間: 2025-3-27 10:02
Allogeneic Transplantation for Acute Lymphoblastic Leukemiaemotherapy treatment for children and adults with the disease. This review summarizes current indications for bone marrow transplantation (BMT) in ALL and recent BMT results. It focuses on the major problem of relapse after BMT identifying predisposing factors and treatment approaches and describes attempts to reduce relapse.作者: invert 時(shí)間: 2025-3-27 15:33
Allogeneic and Syngeneic Marrow Transplantation for Aplastic Anemia: Overview of Seattlepatients had partial or complete spontaneous hematologic recoveries sufficient to live without the need for transfusions. These results were subsequently confirmed by the study group in another cohort of patients [2].作者: 槍支 時(shí)間: 2025-3-27 19:26 作者: 暗語 時(shí)間: 2025-3-27 23:50 作者: 本能 時(shí)間: 2025-3-28 05:21
Transfusion-Induced Allosensitization in Marrow Transplant Recipients: Mechanisms and Preventive Meaks post transplant (1,2). The aim of Tx is to provide blood components that are lacking or deficient in the recipient. However, there are undesired Tx effects that are dependent upon factors such as composition of the Tx product, histocompatibility differences between donor and recipient, the immune作者: PATHY 時(shí)間: 2025-3-28 08:14
Utilization of Monoclonal Antibodies for Autologous Bone Marrow Transplantationlymphocytic leukemia (Null-ALL) and in 2 Burkitt’s lymphoma patients after depletion of leukemia or lymphoma cells from transplanted bone marrow with monoclonal antibodies..Patients’ autologous bone marrow cells were harvested and treated in vitro with either the combination of BA—, BA—2 and BA—3 or作者: 泰然自若 時(shí)間: 2025-3-28 11:34 作者: caldron 時(shí)間: 2025-3-28 14:49
Hematopoietic Cell Transplantation in Murine Globoid Cell Leukodystrophy (The Twitcher Mouse)—A Modeymptomatic supportive care. Allogeneic bone marrow transplantation (BMT) may be therapeutic in these disorders by repopulating the lymphohematopoietic and reticuloendothelial systems with enzymatically normal donor-derived cells, thus providing a stable, self-renewing source of enzyme(s) in which th作者: Acumen 時(shí)間: 2025-3-28 21:10
Experimental Basis of Bone Marrow Purging with Chemical and Photodynamic Agentsossibly due to occult leukemic cells contaminating the remission marrow. Although the efficacy of the ex-vivo purging procedure has yet to be definitely established in clinical practice, there are indications that cleansing the marrow is associated with improved survival in some cases (1, 2). To mee作者: 淡紫色花 時(shí)間: 2025-3-28 23:40
Oncogenes in Acute Myelogenous Leukemia analogues of cellular proto-oncogenes in the context of acutely transforming retroviruses, is responsible for neoplastic transformation. Possible mechanisms by which viral or cellular oncogenes can cause neoplastic transformation have been recently reviewed (2,3). Since qualitative and quantitative作者: enchant 時(shí)間: 2025-3-29 05:32
Optimal Timing of Marrow Transplantation for Patients with Acute Nonlymphoblastic and Acute Lymphoblastic leukemia (ALL). However, the optimal time for intervention in a patient’s disease course with marrow transplantation is yet to be determined. The following will briefly review the current situation.作者: 合適 時(shí)間: 2025-3-29 11:14 作者: 夾克怕包裹 時(shí)間: 2025-3-29 14:26
Allogeneic and Autologous Marrow Transplants in Acute Nonlymphoblastic Leukemia (ANLL) (1–4). Problems with marrow transplantation such as leukemia relapse, graft-versus-host disease (GVHD) and viral infections have been identified and solutions to these problems are being actively pursued in many centers around the world.作者: 紡織品 時(shí)間: 2025-3-29 17:09
Allogeneic Transplantation for Acute Lymphoblastic Leukemiao exceed 2000 allografts and possibly up to 1000 autografts.(1) It is therefore possible to define the success of transplant procedures in some detail and to determine the best treatment option for the individual patient with ALL. This becomes increasingly important with the emergence of improved ch作者: 蟄伏 時(shí)間: 2025-3-29 23:12 作者: 我不死扛 時(shí)間: 2025-3-30 00:28 作者: Comedienne 時(shí)間: 2025-3-30 06:31
Allogeneic Bone Marrow Transplantation for Leukemia—Japanese Experience in 1980 after the formation of the Japan BMT study group of 31 hospitals supported by a grant from the Ministry of Health and Welfare of Japan. This paper reports the data obtained from the registry of the Japanese study group. Member hospitals are listed in Table 1.作者: Instinctive 時(shí)間: 2025-3-30 11:16
Allogeneic and Syngeneic Marrow Transplantation for Aplastic Anemia: Overview of Seattle study of the International Aplastic Anemia Study Group showed that newly diagnosed patients with severe aplastic anemia treated by supportive therapy with or without androgens had a survival of only 20% at 5 years, with most patients dying within the first 6 months of diagnosis [1]. Most surviving 作者: Overstate 時(shí)間: 2025-3-30 14:27 作者: 輕信 時(shí)間: 2025-3-30 17:04 作者: 無政府主義者 時(shí)間: 2025-3-30 23:17 作者: recede 時(shí)間: 2025-3-31 00:57 作者: alabaster 時(shí)間: 2025-3-31 08:02 作者: 值得尊敬 時(shí)間: 2025-3-31 10:00 作者: BRIBE 時(shí)間: 2025-3-31 16:04 作者: 輕率的你 時(shí)間: 2025-3-31 17:33
Vektoren und Vektorrechnung,indigkeit und deren Richtung. Die Kraft, die an einem Massenpunkt angreift, wird beschrieben durch die L?nge der Kraft und der Richtung, unter welcher die Kraft angreift. Immer wenn in Physik und Technik Gr??en auftreten, die sich die durch Ma?zahl (L?nge) und Richtung beschreiben lassen, spricht man von Vektoren.作者: maladorit 時(shí)間: 2025-3-31 22:01
Schools of Pastoralism. Between Institutions, Groups of Interest, Local/Regional Stakeholders and Na of such a sector or addressed in a very top-down way. The a. is presently involved in several Schools of pastoralism and she thinks that a first critical evaluation of their strengths and weaknesses can be advanced.作者: Anticonvulsants 時(shí)間: 2025-4-1 05:03 作者: acrimony 時(shí)間: 2025-4-1 06:32 作者: 撕裂皮肉 時(shí)間: 2025-4-1 12:51
Phenotyping Microarrays for the Characterization of Environmental Microorganisms,of large amounts of data, which require specific approaches for summarization and analysis. Liquid handling automation will increase the feasibility of custom phenotyping arrays that include hydrocarbons and lipids.作者: 不能強(qiáng)迫我 時(shí)間: 2025-4-1 15:18
2198-9842 d legal history in contemporary Brazil, focusing on the time of the transition (and its effects on transitional justice) with different perspectives, from racial and gender issues to constitutional reform and p978-3-030-67504-2978-3-030-67502-8Series ISSN 2198-9842 Series E-ISSN 2198-9850 作者: Insulin 時(shí)間: 2025-4-1 22:27 作者: 儲(chǔ)備 時(shí)間: 2025-4-2 00:06
nformationsbedürfnis von internen und externen Adressaten und dem Streben nach Profi- bilit?tssteigerungen oftmals ohnehin in einem Transformationsprozess befindet. Der - spruch, ein Kreditinstitut vollst?ndig und immer detaillierter in allen bilanz-, risik978-3-8349-8201-8作者: 浪費(fèi)物質(zhì) 時(shí)間: 2025-4-2 02:58
